Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
- Buy Motif Bio (MTFB) by Northland Capital
- Buy Venture Life Group (VLG) by Northland Capital
- Buy Quilter (QLT) by UBS
- Buy Falanx Group Ltd (FLX) by Tom Winnifrith in Hot Stock Rockets
- Buy The City Pub Group (CPC) by Berenberg
- Buy Premaitha Health (NIPT) by Tom Winnifrith in Hot Stock Rockets
- Hold Big Sofa Technologies Group (BST) by Tom Winnifrith in Hot Stock Rockets
- Buy Pan African Resources (PAF) by Numis
- Buy Hvivo (HVO) by Numis
- Hold Jupiter Fund Management (JUP) by Numis
- Buy BAE Systems (BA.) by Royston Wild in The Motley Fool
- Avoid United Carpets Group (UCG) by Steve Moore in ShareProphets
- Buy Morgan Sindall Group (MGNS) by Roland Head in The Motley Fool
- Buy IG Group Holdings (IGG) by Peter Stephens in The Motley Fool
- Buy Petrofac Ltd. (PFC) by Peter Stephens in The Motley Fool
- Sell Seeing Machines Ltd. (SEE) by Steve Moore in ShareProphets
- Sell Victoria (VCP) by Lucian Miers in ShareProphets
- Buy Diageo (DGE) by Roland Head in The Motley Fool
- Buy Croda International (CRDA) by Roland Head in The Motley Fool
- Buy Premier Oil (PMO) by Peter Stephens in The Motley Fool
GlaxoSmithKline (GSK)
Pharma and Biotech Sector
-
Latest quote
1,485.80p (mid)
-
Current Change (%)
-0.72%
-
Price
Bid: 1,486.00p
Offer: 1,486.20p
-
Today
High: 1,496.20p
Low: 1,478.40p
-
This year
High: 1,619.40p
Low: 1,242.80p
-
Information
Volume: 4,657,334
Market Cap: £73715.52M
GlaxoSmithKline Overview
UK-based GlaxoSmithKline is one of the world's leading pharmaceutical research companies. The company was created out of the merger between GlaxoWellcome and SmithKline Beecham in 2000.GlaxoSmithKline RNS Feed
| Title | Release date |
|---|---|
| ViiV submits HIV 2DR regulatory application to EMA | 09:00 - September 14, 2018 |
| Director/PDMR Shareholding | 17:43 - September 12, 2018 |
| New analysis on efficacy of anti-IL5 biologics SEA | 08:00 - September 10, 2018 |
| GSK receives CRL from FDA for mepolizumab in COPD | 07:00 - September 10, 2018 |
| Director/PDMR Shareholding | 14:24 - September 7, 2018 |
| Director/PDMR Shareholding | 14:18 - September 7, 2018 |
| Total Voting Rights | 17:00 - September 3, 2018 |
| GSK publishes Q4 2018 Dividend Dates | 17:12 - August 30, 2018 |
| EU approve Nucala in severe asthma in children | 08:12 - August 30, 2018 |
| Director/PDMR Shareholding | 10:16 - August 24, 2018 |
| Positive headline results for ViiV HC ATLAS study | 07:00 - August 15, 2018 |
| Director/PDMR Shareholding | 15:00 - August 10, 2018 |
| Director/PDMR Shareholding | 12:35 - August 8, 2018 |
| Iain Mackay appointed GSK Chief Financial Officer | 07:00 - August 7, 2018 |
| Publication of Base Prospectus | 17:07 - August 2, 2018 |
NOTE: This is based on 199 open tips for this company
